A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT02358395 · COMPLETED
Trial details
- NCT number
- NCT02358395
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-11-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.